Skip to main content
LBRX logo

LBRX · Lb Pharmaceuticals Inc

$30.90 -0.51 (-1.62%) At close · Jul 20
Market Cap
$886.11M
Shares
28.68M

Total shares sold short and not yet covered, reported to FINRA by broker-dealers and published twice a month (bi-monthly). Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.

Short Squeeze Score
69/100
Short interest 15.9% of shares — P96 Days to cover 9.8 — P95 Price vs VWAP +0.5% — P59 Short-volume trend -26.7% — P4 Short interest change +5.8% — P60 Worst FTD 0.03% of shares — P59

Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-06-30). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-06-30 4,550,288 4,302,626 +247,662 9.78
2026-06-15 4,302,626 4,015,182 +287,444 24.75
2026-05-29 4,015,182 4,018,158 -2,976 21.81
2026-05-15 4,018,158 3,799,720 +218,438 31.18
2026-04-30 3,799,720 3,110,447 +689,273 14.77
2026-04-15 3,110,447 2,621,739 +488,708 8.80
2026-03-31 2,621,739 2,713,021 -91,282 9.53
2026-03-13 2,713,021 2,615,602 +97,419 12.48
2026-02-27 2,615,602 2,199,776 +415,826 12.27
2026-02-13 2,199,776 1,804,088 +395,688 12.35
2026-01-30 1,804,088 1,790,725 +13,363 10.12
2026-01-15 1,790,725 1,833,981 -43,256 6.94
2025-12-31 1,833,981 464,576 +1,369,405 2.70
2025-12-15 464,576 242,536 +222,040 1.71
2025-11-28 242,536 249,832 -7,296 1.75
2025-11-14 249,832 223,012 +26,820 2.29
2025-10-31 223,012 276,214 -53,202 2.86
2025-10-15 276,214 198,541 +77,673 1.16
2025-09-30 198,541 126,558 +71,983 1.34
2025-09-15 126,558 0 +126,558 1.00
Showing 1–20 of 20 settlements
Key facts CIK 1691082 CUSIP 50180M108 13F (30d) 5 filings 5 filers Visit website Investor relations